Rapt Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
RAPT Nasdaq 8731 https://rapt.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rapt Therapeutics Inc

RAPT Therapeutics, Inc. (RAPT): Worst 52-Week Low Stock to Buy Now - Sep 29th, 2024 11:57 am
RAPT Therapeutics, Inc. (RAPT) Stock Falls Following FDA Setback; Short Sellers Cite Unprofitability - Sep 25th, 2024 3:34 pm
RAPT Therapeutics Reports Second Quarter 2024 Financial Results - Aug 8th, 2024 12:00 pm
Should You Sell Your Stake in RAPT Therapeutics (RAPT)? - Jun 21st, 2024 5:13 am
Down -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround - Jun 14th, 2024 1:35 pm
Rapt Therapeutics (RAPT) Loses -47.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - May 29th, 2024 1:35 pm
Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks - May 13th, 2024 1:35 pm
Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation - May 12th, 2024 1:18 pm
RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview - May 10th, 2024 7:46 pm
What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday? - May 9th, 2024 8:12 pm
RAPT Therapeutics Shares Plunge After Wider Q1 Loss, Closing of Zelnecirnon Trials - May 9th, 2024 6:31 pm
RAPT Therapeutics Reports First Quarter 2024 Financial Results - May 9th, 2024 12:00 pm
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients - Apr 9th, 2024 4:00 pm
What Makes RAPT Therapeutics (RAPT) an Investment Choice? - Mar 22nd, 2024 9:39 am
Should You Buy RAPT Therapeutics (RAPT) Ahead of Earnings? - Mar 7th, 2024 1:36 pm
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results - Mar 7th, 2024 1:00 pm
RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting - Mar 5th, 2024 9:30 pm
Insider Buyers Lose Additional US$63k As RAPT Therapeutics Dips To US$236m - Feb 21st, 2024 10:32 am
Rapt Therapeutics Crashes 74% After Unexpected Liver Failure Sidelines Two Tests - Feb 20th, 2024 9:03 pm
UPDATE 1-FDA puts on hold two Rapt Therapeutics mid-stage drug trials - Feb 20th, 2024 12:58 pm